These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38383258)

  • 1. Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context.
    Kohan A; Hinzpeter R; Kulanthaivelu R; Mirshahvalad SA; Avery L; Tsao M; Li Q; Ortega C; Metser U; Hope A; Veit-Haibach P
    Acad Radiol; 2024 Jul; 31(7):2953-2961. PubMed ID: 38383258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
    Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
    Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
    Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
    Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.
    Le NQK; Kha QH; Nguyen VH; Chen YC; Cheng SJ; Chen CY
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
    Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
    Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.
    Rizzo S; Raimondi S; de Jong EEC; van Elmpt W; De Piano F; Petrella F; Bagnardi V; Jochems A; Bellomi M; Dingemans AM; Lambin P
    Eur J Radiol; 2019 Jan; 110():148-155. PubMed ID: 30599853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
    Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
    Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
    Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J
    Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of machine learning in preoperative identification of genetic mutation status in lung cancer: A systematic review and meta-analysis.
    Chen J; Chen A; Yang S; Liu J; Xie C; Jiang H
    Radiother Oncol; 2024 Jul; 196():110325. PubMed ID: 38734145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy.
    Shepherd FA; Lacas B; Le Teuff G; Hainaut P; Jänne PA; Pignon JP; Le Chevalier T; Seymour L; Douillard JY; Graziano S; Brambilla E; Pirker R; Filipits M; Kratzke R; Soria JC; Tsao MS;
    J Clin Oncol; 2017 Jun; 35(18):2018-2027. PubMed ID: 28453411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic Detection of EGFR Mutations in NSCLC.
    Rossi G; Barabino E; Fedeli A; Ficarra G; Coco S; Russo A; Adamo V; Buemi F; Zullo L; Dono M; De Luca G; Longo L; Dal Bello MG; Tagliamento M; Alama A; Cittadini G; Pronzato P; Genova C
    Cancer Res; 2021 Feb; 81(3):724-731. PubMed ID: 33148663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between CT based radiomics features and gene expression data in non-small cell lung cancer.
    Wang T; Gong J; Duan HH; Wang LJ; Ye XD; Nie SD
    J Xray Sci Technol; 2019; 27(5):773-803. PubMed ID: 31450540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features.
    Ahmadian M; Bodalal Z; van der Hulst HJ; Vens C; Karssemakers LHE; Bogveradze N; Castagnoli F; Landolfi F; Hong EK; Gennaro N; Pizzi AD; Beets-Tan RGH; van den Brekel MWM; Castelijns JA
    Comput Biol Med; 2024 May; 174():108389. PubMed ID: 38593640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients.
    Lee SM; Bae SK; Jung SJ; Kim CK
    Clin Nucl Med; 2015 Dec; 40(12):950-8. PubMed ID: 26359571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report.
    Fang C; Zhang C; Zhao WQ; Hu WW; Wu J; Ji M
    BMC Med Genomics; 2019 Oct; 12(1):136. PubMed ID: 31619231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
    Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
    Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Identification of
    Zhang T; Xu Z; Liu G; Jiang B; de Bock GH; Groen HJM; Vliegenthart R; Xie X
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.
    Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.